These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1822794)

  • 21. Unusual expression and very mild course of Xp21 muscular dystrophy (Becker type) in a 60-year-old man with 26 percent deletion of the dystrophin gene.
    Palmucci L; Doriguzzi C; Mongini T; Restagno G; Chiadò-Piat L; Maniscalco M
    Neurology; 1994 Mar; 44(3 Pt 1):541-3. PubMed ID: 8145928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T; Stuettgen P; Cremer M; Goebel HH
    Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the maintainance of the C-terminus domain of dystrophin enough to ensure a milder Becker muscular dystrophy phenotype?
    Vainzof M; Takata RI; Passos-Bueno MR; Pavanello RC; Zatz M
    Hum Mol Genet; 1993 Jan; 2(1):39-42. PubMed ID: 8490621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dystrophin immunohistochemistry in a symptomatic carrier of Becker muscular dystrophy.
    Haginoya K; Yamamoto K; Iinuma K; Yanagisawa T; Ichinohasama Y; Shimmoto M; Suzuki Y; Tada K
    J Neurol; 1991 Oct; 238(7):375-8. PubMed ID: 1683669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscular dystrophy, mental retardation and cardiomyopathy not associated with dystrophin deficiency.
    Villanova M; Malandrini A; Biancotti R; Löfgren A; Mongini T; Six J; Salvestroni R; Parrotta E; Van Broeckhoven C; Paolozzi C; Guazzi G
    Neuromuscul Disord; 1996 May; 6(3):167-72. PubMed ID: 8784804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of spinal muscular atrophy with marked calf hypertrophy and adolescent onset].
    Hattori N; Nishigaki T; Inui K; Kaido M; Nishimura T; Hazama T; Nakata T
    Rinsho Shinkeigaku; 2000 Feb; 40(2):170-3. PubMed ID: 10835940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal dystrophin expression in patients with limb girdle syndromes.
    Beyenburg S; Zierz S; Arahata K; Mundegar RR; Friedl W; Jerusalem F
    J Neurol; 1994 Feb; 241(4):210-7. PubMed ID: 8195819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manifesting carriers of Xp21 muscular dystrophy; lack of correlation between dystrophin expression and clinical weakness.
    Sewry CA; Sansome A; Clerk A; Sherratt TG; Hasson N; Rodillo E; Heckmatt JZ; Strong PN; Dubowitz V
    Neuromuscul Disord; 1993 Mar; 3(2):141-8. PubMed ID: 8358239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of dystrophinopathy by skin biopsy.
    Niiyama T; Higuchi I; Sakoda S; Matsumura T; Fukunaga H; Osame M
    Muscle Nerve; 2002 Mar; 25(3):398-401. PubMed ID: 11870717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatic mosaicism for a deletion of the dystrophin gene in a carrier of Becker muscular dystrophy.
    Voit T; Neuen-Jacob E; Mahler V; Jauch A; Cremer M
    Eur J Pediatr; 1992 Feb; 151(2):112-6. PubMed ID: 1537352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of dystrophin and spectrin in regenerating muscle fibers from Becker dystrophy patients.
    Fanin M; Pegoraro E; Angelini C
    J Neurol Sci; 1994 May; 123(1-2):88-94. PubMed ID: 8064327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history.
    Bushby KM; Gardner-Medwin D
    J Neurol; 1993 Feb; 240(2):98-104. PubMed ID: 8437027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy.
    Muntoni F; Mateddu A; Cianchetti C; Marrosu MG; Clerk A; Cau M; Congiu R; Cao A; Melis MA
    J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):26-31. PubMed ID: 8429320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: an updated protocol.
    van Essen AJ; Kneppers AL; van der Hout AH; Scheffer H; Ginjaar IB; ten Kate LP; van Ommen GJ; Buys CH; Bakker E
    J Med Genet; 1997 Oct; 34(10):805-12. PubMed ID: 9350811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-blind study of dystrophin staining in carriers of Duchenne muscular dystrophy.
    Bernier FP; Greenberg CR; Halliday WC; Wrogemann K
    Can J Neurol Sci; 1993 Feb; 20(1):44-7. PubMed ID: 8467428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Specificity of the dystrophin immunohistochemical technique in muscular dystrophy].
    Colomer Oferil J; Vila Torres J; Huezo Montoya C
    Neurologia; 1993 May; 8(5):112-5. PubMed ID: 8507503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Becker-like muscular dystrophy in sisters.
    Diószeghy P; Molnár M; Mechler F
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(6):326-30. PubMed ID: 8527470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymptomatic Becker muscular dystrophy: histological changes in biopsied muscles.
    Tachi N; Watanabe Y; Ohya K; Chiba S
    Acta Paediatr Jpn; 1993 Oct; 35(5):409-11. PubMed ID: 8256625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dystrophin analysis in Duchenne and Becker muscular dystrophy carriers: correlation with intracellular calcium and albumin.
    Morandi L; Mora M; Gussoni E; Tedeschi S; Cornelio F
    Ann Neurol; 1990 Nov; 28(5):674-9. PubMed ID: 1979724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dystrophin or a "related protein" in Duchenne muscular dystrophy?
    Nicholson LV; Johnson MA; Davison K; O'Donnell E; Falkous G; Barron M; Harris JB
    Acta Neurol Scand; 1992 Jul; 86(1):8-14. PubMed ID: 1519480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.